Abstract:Bartter syndrome is a group of rare genetic disorders that compromise kidney function by impairing electrolyte reabsorption. Left untreated, the resulting hyponatremia, hypokalemia, and dehydration can be fatal, and there is currently no cure. Bartter syndrome type II specifically arises from mutations in KCNJ1, which encodes the renal outer medullary potassium channel, ROMK. Over 40 Bartter syndrome-associated mutations in KCNJ1 have been identified, yet their molecular defects are mostly uncharacterized. Nevertheless, a subset of disease-linked mutations compromise ROMK folding in the endoplasmic reticulum (ER), which in turn results in premature degradation via the ER associated degradation (ERAD) pathway. To identify uncharacterized human variants that might similarly lead to premature degradation and thus disease, we mined three genomic databases. First, phenotypic data in the UK Biobank were analyzed using a recently developed computational platform to identify individuals carrying KCNJ1 variants with clinical features consistent with Bartter syndrome type II. In parallel, we examined genomic data in both the NIH TOPMed and ClinVar databases with the aid of Rhapsody, a verified computational algorithm that predicts mutation pathogenicity and disease severity. Subsequent phenotypic studies using a yeast screen to assess ROMK function-and analyses of ROMK biogenesis in yeast and human cells-identified four previously uncharacterized mutations. Among these, one mutation uncovered from the two parallel approaches (G228E) destabilized ROMK and targeted it for ERAD, resulting in reduced cell surface expression. Another mutation (T300R) was ERAD-resistant, but defects in channel activity were apparent based on two-electrode voltage clamp measurements in X. laevis oocytes. Together, our results outline a new computational and experimental pipeline that can be applied to identify disease-associated alleles linked to a range of other potassium channels, and further our understanding of the ROMK structure-function relationship that may aid future therapeutic strategies to advance precision medicine.

Paradoxes in magnesium transport in Type 1 Bartter's syndrome and Gitelman's syndrome: a modeling analysis

How the kidney regulates magnesium: a modelling study

Genetics of Magnesium Disorders

Digenetic Inheritance of SLC12A3 and CLCNKB Genes in a Chinese Girl with Gitelman Syndrome

NaCl cotransporter activity and Mg2+ handling by the distal convoluted tubule

Magnesium reabsorption in the kidney

[Advance in Genetic Research on Gitelman Syndrome].

Molecular determinants of magnesium homeostasis: insights from human disease

Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity

Sodium/Glucose Cotransporter 2 Inhibitors and Magnesium Homeostasis

Molecular Mechanisms of Renal Magnesium Reabsorption

A Novel Compound Heterozygous Variant of the SLC12A3 Gene in Gitelman Syndrome Pedigree

Magnesium Biology

A Chinese Girl with Bartter Syndrome Type III Due to a Novel Mutation And/or Single Nucleotide Polymorphisms (snps) in CLCNKB Gene

Genome mining yields putative disease-associated ROMK variants with distinct defects

Sex differences in renal transporters: assessment and functional consequences

Renal diseases that course with hypomagnesemia. Comments on a new hereditary hypomagnesemic tubulopathy

Adult classic Bartter syndrome: a case report with 5-year follow-up and literature review

Cardiovascular and arrhythmic manifestations of Bartter's and Gitelman's syndromes: do not forget the heart. A narrative literature review

Renal Calcium and Magnesium Handling During Pregnancy: Modeling and Analysis

Modulation of blood pressure by dietary potassium and sodium: Sex differences and modeling analysis